Investing.com - Verona Pharma (NASDAQ:VRNA) ADR reported on Tuesday second quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Verona Pharma ADR announced earnings per share of $-0.04 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.2175 on revenue of $0.00.
Verona Pharma ADR shares are up 8.56% from the beginning of the year, still down 4.14% from its 52 week high of $7.25 set on December 27, 2021. They are outperforming the Nifty 50 which is up 0.99% from the start of the year.
Verona Pharma ADR shares gained 72.66% in pre-market trade following the report.
Verona Pharma ADR follows other major Healthcare sector earnings this month
Verona Pharma ADR's report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar